Filing Details
- Accession Number:
- 0000874716-24-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-20 17:00:34
- Reporting Period:
- 2024-05-17
- Accepted Time:
- 2024-05-20 17:00:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403694 | L. Bruce Claflin | One Idexx Drive Westbrook ME 04092 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-05-17 | 200 | $540.80 | 161 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,560 | Indirect | by Claflin Family Trust |
Footnotes
- Shares of Issuer common stock held by the Claflin Family Trust ('Trust') of which the reporting person's spouse is the trustee for the benefit of the reporting person's spouse and children. The reporting person disclaims beneficial ownership of the shares held in the Trust and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.